Eom Pharmaceutical Holdings Inc (IMUC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,889 | -5,720 | -4,221 | -4,309 | -2,758 |
| Depreciation Amortization | 11 | 20 | 14 | 8 | 4 |
| Accounts payable and accrued liabilities | -431 | 963 | 78 | -108 | -121 |
| Other Working Capital | -787 | 1,026 | 167 | 87 | -69 |
| Other Operating Activity | 5,517 | -2,673 | -636 | 1,513 | 1,409 |
| Operating Cash Flow | $-3,579 | $-6,384 | $-4,599 | $-2,810 | $-1,535 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -84 | -65 | -38 | -38 |
| Investing Cash Flow | $-6 | $-84 | $-65 | $-38 | $-38 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,371 | 7,360 | 7,460 | 7,623 | 7,460 |
| Common Stock Repurchased | 0 | 388 | 383 | N/A | 48 |
| Other Financing Activity | 1,116 | 53 | 53 | 53 | 0 |
| Financing Cash Flow | $10,487 | $7,802 | $7,896 | $7,676 | $7,508 |
| Beginning Cash Position | 6,653 | 5,320 | 5,320 | 5,320 | 5,320 |
| End Cash Position | 13,556 | 6,653 | 8,551 | 10,148 | 11,254 |
| Net Cash Flow | $6,903 | $1,333 | $3,232 | $4,828 | $5,934 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,579 | -6,384 | -4,599 | -2,810 | -1,535 |
| Capital Expenditure | -6 | -84 | -65 | -38 | -38 |
| Free Cash Flow | -3,584 | -6,468 | -4,664 | -2,848 | -1,573 |